23 Jul, 2026
According to Straits Research, the global surgical lasers market size was valued at $8.86 billion in 2025 and is projected to grow from $9.81 billion in 2026 to $22.2 billion by 2034 at a CAGR of 10.75% during the forecast period 2026-2034.
Surgical laser products are used during laser treatments for a variety of procedures, such as the removal of moles and tattoos, the cutting or destruction of abnormal or diseased tissues, the reduction or elimination of lesions and tumors, the sealing of lymph arteries, and the blockage of blood vessels and nerve endings. They are used in various treatments, including open, laparoscopic, percutaneous, gynecological, dermatological, urological, cardiologic, oncological, ophthalmic, and dental procedures. Surgical lasers can heal soft tissue by heating it, which helps hasten the healing process for patients. They are used in reconstructive surgery and the treatment of conditions like cancer because of their ability to concentrate on specific tissue layers.
As surgical lasers are used more often to address chronic illnesses, including diabetes, cardiovascular disease, multiple sclerosis, and asthma, and significantly lower healthcare costs, the market is expected to grow. In 2019, 463 million individuals between the ages of 20 and 79 will have diabetes globally, predicts the International Diabetes Federation (IDF). That figure is anticipated to rise to 700 million by 2045. The IDF estimates that another 374 million people are at high risk of developing type 2 diabetes. The IDF estimates that half of all diabetes patients in Asia reside in China and India. According to the IDF, the Western Pacific region, consisting of China, Japan, Malaysia, Australia, and Indonesia, is one of the most inhabited regions globally and now has 138.2 million diabetics. That number is predicted to increase to 201.8 million by 2035
Technological advancements, rising product adoption rates, partnerships and cooperation among large firms, and industry development contribute to this. For instance, the next-generation ALLY Adaptive Cataract Treatment System from LENSAR, Inc., a medical technology firm that specializes in cutting-edge femtosecond laser surgical solutions for the treatment of cataracts, received 510(k) approval from the US Food and Drug Administration. The Eye Institute of West Florida used the ALLY Adaptive Cataract Treatment System for the first time in a professional environment in August 2022. It is anticipated that these changes will speed up market growth. As a result of the factors, the market under examination is projected to expand throughout the inquiry. However, laser surgery's exorbitant procedure costs will undoubtedly restrain industry expansion.
North America is the most significant Global Surgical Lasers Market shareholder and is estimated to grow at a CAGR of 10.9% over the forecast period. The presence of modern healthcare infrastructure, the high acceptance rates of technologically advanced aesthetic laser technologies, and the rise in demand for cosmetic and aesthetic procedures all contribute to this supremacy. Additional factors anticipated to promote market development include the local presence of large corporations and their continuous strategic initiatives. The American Society of Plastic Surgeons (ASPS) projected 316,886 ablative laser-assisted skin resurfacing operations in the United States in 2016, up from 326,120 procedures in 2015. Due to favorable reimbursement regulations, as well as increased demand for less invasive ophthalmic and cosmetic procedures, the market is expected to grow. Due to the presence of several industry players, this region also has the largest market share.
Europe is anticipated to exhibit a CAGR of 10.7% over the forecast period. Due to mature economies and benevolent regulatory frameworks, the leading market participants in the area have development potential. As a result, this sector is predicted to see profitable expansion during the projection period. As a result of its better economic structure and high adoption rate of cutting-edge technology, Germany has the biggest market share in the region. Major market growth factors include competitors' use of inorganic development strategies and the rising use of laser dentistry to treat oral mucosal lesions.
sales@straitsresearch.com